AI Chat Paper
Note: Please note that the following content is generated by AMiner AI. SciOpen does not take any responsibility related to this content.
{{lang === 'zh_CN' ? '文章概述' : 'Summary'}}
{{lang === 'en_US' ? '中' : 'Eng'}}
Chat more with AI
Powered by AMiner. Clicking this button will take you away from SciOpen.
Home Food Science and Human Wellness Article
PDF (3.6 MB)
Cite
EndNote(RIS) BibTeX
Collect
Submit Manuscript AI Chat Paper
Show Outline
Outline
Show full outline
Hide outline
Outline
Show full outline
Hide outline
Open Access

Oral administration of egg white ovotransferrin prevents osteoporosis in ovariectomized rats

Nan Shanga,b,c, Xiaoyu Baoa, Michael Doschakd, Jianping Wua( )
Department of Agricultural, Food and Nutritional Science, University of Alberta, Edmonton T6G 2P5, Canada
College of Engineering, China Agricultural University, Beijing 100083, China
Key Laboratory of Precision Nutrition and Food Quality, Department of Nutrition and Healthy, China Agricultural University, Beijing 100193, China
Faculty of Pharmacy & Pharmaceutical Sciences, University of Alberta, Edmonton T6G 2H5, Canada

Peer review under responsibility of Tsinghua University Press.

Show Author Information

Graphical Abstract

Abstract

Ovotransferrin, an iron-binding glycoprotein, accounting for approximately 12% of egg white protein, is a member of transferrin fam ily. Our previous studies showed that ovotransferrin stimulates the proliferation and differentiation of osteoblasts, while inhibits osteoclastogenesis and resorption activity. The work aims to study the efficacy of orally administered ovotransferrin on the prevention of osteoporosis using ovariectomized (OVX) Sprague-Dawley rats. Oral administration of ovotransferrin showed no negative effect on body weight, food intake and organ weight. After 12-week treatment, feeding ovotransferrin at a dose of 1% (1 g ovotransferrin/100 g diet) prevented OVX-induced bone loss and maintained relatively high bone mineral density and integrated bone microarchitecture. The serum concentration of biomarkers indicating bone formation was increased in ovotransferrin administration groups, while the bone resorption biomarkers were decreased. Ovotransferrin feeding also decreased the production of serum cytokine TNF-α and IL-6, which are two stimulators for osteoclast differentiation. In addition to its direct regulatory role on bone turnover, ovotransferrin supplementation might benefit osteoporosis prevention by inhibiting adipogenesis, and regulating immune response. Our results suggested the potential application of ovotransferrin as a functional food ingredient on the prevention of osteoporosis.

Keywords

OvotransferrinOvariectomized (OVX) ratsBone mineral densityBone microarchitectureBone resorptionInflammation

References

[1]

B. Kim, Y.J. Cho, W.L. Lim, Osteoporosis therapies and their mechanisms of action (review), Exp Ther. Med. 22(2021) 1379. https://doi.org/10.3892/etm.2021.10815.
Crossref Google Scholar
[2]

M.X. Ji, Q. Yu, Primary osteoporosis in postmenopausal women, Chronic Dis. Transl. Med. 1 (2015) 9-13. https://doi.org/10.1016/j.cdtm.2015.02.006.
Crossref Google Scholar
[3]

T.J. de Villiers, M.L.S. Gass, C.J. Haines, et al., Global consensus statement on menopausal hormone therapy, Climacteric. 16 (2013) 203-204. https://doi.org/10.3109/13697137.2013.771520.
Crossref Google Scholar
[4]

M.M. Rahman, A. Bhattacharya, J. Banu, et al., Endogenous n-3 fatty acids protect ovariectomy induced bone loss by attenuating osteoclastogenesis, J. Cell Mol. Med. 13 (2009) 1833-1844. https://doi.org/10.1111/j.1582-4934.2009.00649.x.
Crossref Google Scholar
[5]

O. Fromigué, D. Modrowski, P.J. Marie, Growth factors and bone formation in osteoporosis: roles for fibroblast growth factor and transforming growth factor beta, Curr. Pharm. Des. 10 (2004) 2593-2603. https://doi.org/10.2174/1381612043383773.
Crossref Google Scholar
[6]

A. Giustina, G. Mazziotti, E. Canalis, Growth hormone, insulin-like growth factors, and the skeleton, Endocr. Rev. 29 (2008) 535-559. https://doi.org/10.1210/er.2007-0036.
Crossref Google Scholar
[7]

E. Smith, R.A. Redman, C.R. Logg, et al., Glucocorticoids inhibit developmental stage-specific osteoblast cell cycle: dissociation of cyclin A-cyclin-dependent kinase 2 from E2F4-p130 complexes, J. Biol. Chem. 275 (2000) 19992-20001. https://doi.org/10.1074/jbc.M001758200.
Crossref Google Scholar
[8]

J.W. Nieves, Osteoporosis: the role of micronutrients, Am. J. Clin. Nutr. 81 (2005) 1232S-1239S. https://doi.org/10.1093/ajcn/81.5.1232.
Crossref Google Scholar
[9]

T. Wilsgaard, N. Emaus, L.A. Ahmed, et al., Lifestyle impact on lifetime bone loss in women and men, Am. J. Epidemiol. 169 (2009) 877-886. https://doi.org/10.1093/aje/kwn407.
Crossref Google Scholar
[10]

M.T. Drake, B.L. Clarke, S. Khosla, Bisphosphonates: mechanism of action and role in clinical practice, Mayo Clin. Proc. 83 (2008) 1032-1045. https://doi.org/10.4065/83.9.1032.
Crossref Google Scholar
[11]

J. Crockett, J.C. Das, Osteoporosis-a current view of pharmacological prevention and treatment, Drug Des. Dev. Ther. 7 (2013) 435. https://doi.org/10.2147/DDDT.S31504.
Crossref Google Scholar
[12]

B.H. Arjmandi, E.A. Lucas, D.A. Khalil, et al., One year soy protein supplementation has positive effects on bone formation markers but not bone density in postmenopausal women, Nutr. J. 4 (2005) 8. https://doi.org/10.1186/1475-2891-4-8.
Crossref Google Scholar
[13]

A.M. Kenny, K.M. Mangano, R.H. Abourizk, et al., Soy proteins and isoflavones affect bone mineral density in older women: a randomized controlled trial, Am. J. Clin. Nutr. 90 (2009) 234-242. https://doi.org/10.3945/ajcn.2009.27600.
Crossref Google Scholar
[14]

M. Messina, V. Messina, Soyfoods, soybean isoflavones, and bone health: a brief overview, J. Renal Nutr. 10 (2000) 63-68. https://doi.org/10.1016/s1051-2276(00)90001-3.
Crossref Google Scholar
[15]

X. Zheng, S. Lee, O.K. Chun, et al., Soy isoflavones and osteoporotic bone loss: a review with an emphsis on modulation of bone remodeling, J. Med. Food 19 (2016) 1-14. https://doi.org/10.1089/jmf.2015.0045.
Crossref Google Scholar
[16]

X. Zhang, X. Shu, H. Li, et al., Prospective cohort study of soy food consumption and risk of bone fracture among postmenopausal woman, Arch. Intern. Med. 165 (2005) 1890-1895. https://doi.org/10.1001/archinte.165.16.1890.
Crossref Google Scholar
[17]

J. Cornish, K.E. Callon, D. Naot, et al., Lactoferrin is a potent regulator of bone cell activity and increases bone formation in vivo, Endocrinology 14 (2004) 4366-4374. https://doi.org/10.1210/en.2003-1307.
Crossref Google Scholar
[18]

A. Grey, Q. Zhu, M. Watson, et al., Lactoferrin potently inhibits osteoblast apoptosis, via an LRP1-independent pathway, Mol. Cell. Endocrinol. 251 (2006) 96-102. https://doi.org/10.1016/j.mce.2006.03.002.
Crossref Google Scholar
[19]

M. Yagi, N. Suzuki, T. Takayama, et al., Effects of lactoferrin on the differentiation of pluripotent mesenchymal cells, Cell Biol. Int. 33 (2009) 283-289. https://doi.org/10.1016/j.cellbi.2008.11.013.
Crossref Google Scholar
[20]

O.M. Conneely, Antiinflammatory activities of lactoferrin, J. Am. Coll. Nutr. 20(5 Suppl) (2001) 389S-397S. https://doi.org/10.1080/07315724.2001.10719173.
Crossref Google Scholar
[21]

J. Legros, S. Jan, S. Bonnassie, et al., The role of ovotransferrin in egg-white antimicrobial activity: a review, Foods 10 (2021) 823. https://doi.org/10.3390/foods10040823.
Crossref Google Scholar
[22]

J. Wu, A. Acero-Lopez, Ovotransferrin: structure, bioactivities, and preparation, Food Res. Int. 46 (2012) 480-487. https://doi.org/10.1016/J.FOODRES.2011.07.012.
Crossref Google Scholar
[23]

N. Shang, J. Wu, Egg white ovotransferrin shows osteogenic activity in osteoblast cells, J. Agric. Food Chem. 66 (2018) 2775-2782. https://doi.org/10.1021/acs.jafc.8b00069.
Crossref Google Scholar
[24]

N. Shang, J. Wu, Egg white ovotransferrin attenuates RANKL-induced osteoclastogenesis and bone resorption, Nutrients 11 (2019) 2254. https://doi.org/10.3390/nu11092254.
Crossref Google Scholar
[25]

Y. Kobayashi, P. Rupa, J. Kovacs-Nolan, et al., Oral administration of hen egg white ovotransferrin attenuates the development of colitis induced by dextran sodium sulfate in mice, J. Agric. Food Chem. 63 (2015) 1532-1539. http://doi.org/10.1021/jf505248n.
Crossref Google Scholar
[26]

E.D.N.S. Abeyrathne, H.Y. Lee, D.U. Ahn, Sequential separation of lysozyme, ovomucin, ovotransferrin, and ovalbumin from egg white, Poult. Sci. 93 (2014) 1001-1009. https://doi.org/10.3382/ps.2013-03403.
Crossref Google Scholar
[27]

M. Le Gars, C. Seiler, A. Kay, et al., CD38 is a key regulator of enhanced NK cell immune responses during pregnancy through its role in immune synapse formation, BioRxiv (2018) 349084. https://doi.org/10.1101/349084.
Crossref Google Scholar
[28]

J. Han, W. Wang, Effects of tanshinol on markers of bone turnover in ovariectomized rats and osteoblast cultures, PLoS One 12 (2017) e0181175. https://doi.org/10.1371/journal.pone.0181175.
Crossref Google Scholar
[29]

B.L. Riggs, The mechanisms of estrogen regulation of bone resorption, J. Clin. Invest. 106 (2000) 1203-1204. https://doi.org/10.1172/JCI11468.
Crossref Google Scholar
[30]

N.A. Hallquist, K.C. Klasing, Serotransferrin, ovotransferrin, and metallothionein levels during an immune response in chickens, Comp. Biochem. Physiol. B Biochem. Mol. Biol. 108 (1994) 375-384. https://doi.org/10.1016/0305-0491(94)90089-2.
Crossref Google Scholar
[31]

F. Levy, P. Bulet, L. Ehret-Sabatier, Proteomic analysis of the systemic immune response of Drosophila, Mol. Cell. Proteomics. 3 (2004) 156-166. https://doi.org/10.1074/mcp.M300114-MCP200.
Crossref Google Scholar
[32]

G. Zhu, J. Luo, H. Du, et al., Ovotransferrin enhances intestinal immune response in cyclophosphamide-induced immunosuppressed mice, Int. J. Biol. Macromol. 120 (2018) 1-9. https://doi.org/10.1016/j.ijbiomac.2018.08.058.
Crossref Google Scholar
[33]

W. Huang, S. Chakrabarti, K. Majumder, et al., Egg-derived peptide IRW inhibits TNF-α-induced inflammatory response and oxidative stress in endothelial cells, J. Agric. Food Chem. 58 (2010) 10840-10846. https://doi.org/10.1371/journal.pone.0082829.
Crossref Google Scholar
[34]

W. Liao, S. Chakrabarti, S.T. Davidge, et al., Modulatory effects of egg white ovotransferrin-derived tripeptide IRW (Ile-Arg-Trp) on vascular smooth muscle cells against angiotensin Ⅱ stimulation, J. Agric. Food Chem. 64 (2016) 7342-7347. https://doi.org/10.1021/acs.jafc.6b03513.
Crossref Google Scholar
[35]

P. Garnero, N. Buchs, J. Zekri, et al., Markers of bone turnover for the management of patients with bone metastases from prostate cancer, Br. J. Cancer. 82 (2000) 858-864. https://doi.org/10.1054/bjoc.1999.1012.
Crossref Google Scholar
[36]

R. Kiviranta, J. Morko, H. Uusitalo, et al., Accelerated turnover of metaphyseal trabecular bone in mice overexpressing cathepsin K, J. Bone Miner. Res. 16 (2001) 1444-1452. https://doi.org/10.1359/jbmr.2001.16.8.1444.
Crossref Google Scholar
[37]

P. Saftig, E. Hunziker, V. Everts, et al., Functions of cathepsin K in bone resorption: lessons from cathepsin K deficient mice, Cellular Peptidases in Immune Functions and Diseases 2 (2002) 293-303. https://doi.org/10.1007/0-306-46826-3_32.
Crossref Google Scholar
[38]

K. Sundaram, R. Nishimura, J. Senn, et al., RANK ligand signaling modulates the matrix metalloproteinase-9 gene expression during osteoclast differentiation, Exp. Cell Res. 313 (2007) 168-178. https://doi.org/10.1016/j.yexcr.2006.10.001.
Crossref Google Scholar
[39]

P. Reponen, C. Sahlberg, C. Munaut, et al., High expression of 92-kD type Ⅳ collagenase (gelatinase B) in the osteoclast lineage during mouse development, J. Cell Biol. 124 (1994) 1091-1102. https://doi.org/10.1083/jcb.124.6.1091.
Crossref Google Scholar
[40]

A.L. Wucherpfennig, Y.P. Li, W.G. Stetler-Stevenson, et al., Expression of 92 kD type Ⅳ collagenase/gelatinase B in human osteoclasts, J. Bone Miner. Res. 9 (1994) 549-556. https://doi.org/10.1002/jbmr.5650090415.
Crossref Google Scholar
[41]

C.H. Tsai, Y.J. Chen, F.M. Huang, et al., The upregulation of matrix metalloproteinase-9 in inflamed human dental pulps, J. Endod. 31 (2005) 860-862. https://doi.org/10.1097/01.don.0000164851.55389.4e.
Crossref Google Scholar
[42]

M. Zhou, Y. Zhang, J. A. Ardans, et al., Interferon-gamma differentially regulates monocyte matrix metalloproteinase-1 and -9 through tumor necrosis factor-alpha and caspase 8, J. Biol. Chem. 278 (2003) 45406-45413. https://doi.org/10.1074/jbc.M309075200.
Crossref Google Scholar
[43]

D. Thummuri, V.G.M. Naidu, P. Chaudhari, Carnosic acid attenuates RANKL-induced oxidative stress and osteoclastogenesis via induction of Nrf2 and suppression of NF-κB and MAPK signalling, J. Mol. Med. 95 (2017) 1065-1076. https://doi.org/10.1007/s00109-017-1553-1.
Crossref Google Scholar
[44]

B. H. Kim, J. H. Oh, N. K. Lee, The inactivation of ERK1/2, p38 and NF-κB is involved in the down-regulation of osteoclastogenesis and function by A2B adenosine receptor stimulation, Mol. Cell. 4 (2017) 752-760. https://doi.org/10.14348/molcells.2017.0098.
Crossref Google Scholar
[45]

Y. Saxena, S. Routh, A. Mukhopadhaya, Immunoporosis: role of innate immune cell in osteoporosis, Front. Immunol. 12 (2021) 687037. https://doi.org/10.3389/fimmu.2021.687037.
Crossref Google Scholar
[46]

M.C. Horowitz, A.L.M. Bothwell, D.G.T. Hesslein, et al., B cells and osteoblast and osteoclast development, Immunol. Rev. 208 (2005) 141-153. https://doi.org/10.1111/j.0105-2896.2005.00328.x.
Crossref Google Scholar
[47]

M.C. Walsh, N. Kim, Y. Kadono, et al., Osteoimmunology: interplay between the immune system and bone metabolism, Annu. Rev. Immunol. 24 (2006) 33-63. https://doi.org/10.1146/annurev.immunol.24.021605.090646.
Crossref Google Scholar
[48]

V. Breuil, M. Ticchioni, J. Testa, et al., Immune changes in post-menopausal osteoporosis: the Immunos study, Osteoporos. Int. 21 (2010) 805-814. https://doi.org/10.1007/s00198-009-1018-7.
Crossref Google Scholar
[49]

E. Hascoet, F. Blanchard, C. Blin-Wakkach, et al., New insights into inflammatory osteoclast precursors as therapeutic targets for rheumatoid arthritis and periodontitis, Bone Res. 11 (2023) 26. https://doi.org/10.1038/s41413-023-00257-w.
Crossref Google Scholar
[50]

J.C. Marie, E. Bonnelye, Effect of estrogens on osteoimmunology: a role in bone metastasis, Front. Immunol. 13 (2022) 899104. https://doi.org/10.3389/fimmu.2022.899104.
Crossref Google Scholar
[51]

Y. Onoe, C. Miyaura, M. Ito, et al., Comparative effects of estrogen and raloxifene on B lymphopoiesis and bone loss induced by sex steroid deficiency in mice, J. Bone Miner. Res. 15 (2010) 541-549. https://doi.org/10.1359/jbmr.2000.15.3.541.
Crossref Google Scholar
Food Science and Human Wellness
Volume 13 Issue 5,
September 2024
Pages 2562-2572
DOI: 10.26599/FSHW.2022.9250249
Cite this article:
Shang N, Bao X, Doschak M, et al. Oral administration of egg white ovotransferrin prevents osteoporosis in ovariectomized rats. Food Science and Human Wellness, 2024, 13(5): 2562-2572. https://doi.org/10.26599/FSHW.2022.9250249

534

Views

40

Downloads

0

Crossref

0

Web of Science

0

Scopus

0

CSCD

Altmetrics
Received: 09 April 2023
Revised: 05 June 2023
Accepted: 31 July 2023
Published: 10 October 2024
© 2024 Beijing Academy of Food Sciences. Publishing services by Tsinghua University Press.

This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
Return